Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation.
Della-Torre E, Lanzillotta M, Campochiaro C, Cavalli G, De Luca G, Tomelleri A, Boffini N, De Lorenzo R, Ruggeri A, Rovere-Querini P, Castagna A, Landoni G, Tresoldi M, Ciceri F, Zangrillo A, Dagna L.
Della-Torre E, et al. Among authors: zangrillo a.
Front Immunol. 2021 Apr 29;12:675678. doi: 10.3389/fimmu.2021.675678. eCollection 2021.
Front Immunol. 2021.
PMID: 33995419
Free PMC article.
Clinical Trial.